Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction  by Tashiro, Katsuhisa et al.
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
www.e l sev i e r . com/ l oca te / sc r
Stem Cell Research (2012) 8, 300–311SHORT REPORT
Promotion of hematopoietic differentiation from
mouse induced pluripotent stem cells by transient
HoxB4 transduction
Katsuhisa Tashiro a, Kenji Kawabata a, b, Miyuki Omori a, b,
Tomoko Yamaguchi a, Fuminori Sakurai b, Kazufumi Katayama b,
Takao Hayakawa c, d, Hiroyuki Mizuguchi a, b, e,⁎a Laboratory of Stem Cell Regulation, National Institute of Biomedical Innovation, 7-6-8, Saito-Asagi, Ibaraki,
Osaka 567-0085, Japan
b Graduate School of Pharmaceutical Sciences, Osaka University, 1-6, Yamadaoka, Suita, Osaka, 565-0871, Japan
c Pharmaceutics and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-Ku, Tokyo 100-0013, Japan
d Pharmaceutical Research and Technology Institute, Kinki University, 3-4-1, Kowakae, Higashi-Osaka, Osaka 577-8502, Japan
e The Center for AdvancedMedical Engineering and Informatics, Osaka University, 1-6, Yamadaoka, Suita, Osaka, 565-0871, JapanReceived 25 April 2011; received in revised form 1 September 2011; accepted 5 September 2011
Available online 16 September 2011Abstract Ectopic expression of HoxB4 in embryonic stem (ES) cells leads to an efficient production of hematopoietic cells,
including hematopoietic stem/progenitor cells. Previous studies have utilized a constitutive HoxB4 expression system or tetracycline-
regulated HoxB4 expression system to induce hematopoietic cells from ES cells. However, these methods cannot be applied
therapeutically due to the risk of transgenes being integrated into the host genome. Here, we report the promotion of hematopoietic
differentiation from mouse ES cells and induced pluripotent stem (iPS) cells by transient HoxB4 expression using an adenovirus
(Ad) vector. Ad vector could mediate efficient HoxB4 expression in ES cell-derived embryoid bodies (ES-EBs) and iPS-EBs, and its
expression was decreased during cultivation, showing that Ad vector transduction was transient. A colony-forming assay revealed
that the number of hematopoietic progenitor cells with colony-forming potential in HoxB4-transduced cells was significantly
increased in comparison with that in non-transduced cells or LacZ-transduced cells. HoxB4-transduced cells also showed more
efficient generation of CD41-, CD45-, or Sca-1-positive cells than control cells. These results indicate that transient, but not
constitutive, HoxB4 expression is sufficient to augment the hematopoietic differentiation of ES and iPS cells, and that our method
would be useful for clinical applications, such as cell transplantation therapy.
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Embryonic stem (ES) cells and induced pluripotent stem (iPS)
cells, each of which is derived from the inner cell mass of
blastocysts and somatic cells by transducing three or four
301Promotion of hematopoietic differentiation by transient HoxB4 transductiontranscription factors, respectively, can differentiate into
various types of cells in vitro. They are thus considered as
a valuable model to understand the processes involved in
the differentiation of lineage-committed cells as well as an
unlimited source of cells for therapeutic applications such
as hematopoietic stem/progenitor cell (HSPC) transplanta-
tion (Evans and Kaufman, 1981; Thomson et al., 1998; Kel-
ler, 2005; Takahashi and Yamanaka, 2006; Takahashi et al.,
2007).
Differentiation of ES and iPS cells into mature hematopoi-
etic cells, including erythrocytes, myeloid cells, and lym-
phoid cells, has been performed by embryoid body (EB)
formation or coculture with stromal cells (Nakano et al.,
1994; Chadwick et al., 2003; Schmitt et al., 2004; Vodyanik
et al., 2005). However, the development of an efficient dif-
ferentiation method for immature hematopoietic cells, in-
cluding HSPCs, from ES and iPS cells has been challenging.
Previously, Daley and his colleagues have shown that
enforced expression of HoxB4 in mouse ES cells by a retrovi-
rus vector robustly enhanced the differentiation of ES cells
into HSPCs in vitro, and these ES cell-derived HSPCs had a
long-term reconstitution potential in vivo (Kyba et al.,
2002; Wang et al., 2005). In addition, constitutive expres-
sion of HoxB4 was shown to induce the hematopoietic differ-
entiation from human ES cells (Bowles et al., 2006). These
findings indicated that manipulation of HoxB4 expression
would be effective for production of HSPCs from ES and iPS
cells. However, it is known that long-term constitutive
HoxB4 expression in HSPCs has an inhibitory effect on the
differentiation of certain hematopoietic lineages, such as
lymphoid cells and erythroid cells (Kyba et al., 2002; Pilat
et al., 2005), and can lead to a significant risk of leukemo-
genesis in large animals (Zhang et al., 2008). Although a tet-
racycline-inducible HoxB4 expression system has been
utilized to overcome these unwanted effects, this gene ex-
pression system is complex, and cannot be directly applied
to therapeutic use. Foreign genes can be integrated into
the host chromosome in a stable gene expression system
that includes a tetracycline-regulated system, and this
could cause an increased risk of cellular transformation (Li
et al., 2002; Hacein-Bey-Abina et al., 2003; Williams and
Baum, 2004). Therefore, to apply ES cell- and iPS cell-de-
rived HSPCs to clinical medicine, development of a simple
and transient HoxB4 transduction method in ES and iPS
cells is required.
We have utilized an adenovirus (Ad) vector as a tool for
transduction of functional genes into stem cells, because Ad
vectors are relatively easy to construct, can be produced at
high titers, andmediate efficient and transient gene expression
in both dividing and nondividing cells. We have demonstrated
that Ad vectors could efficiently transduce a foreign gene in
stem cells, including ES and iPS cells (Kawabata et al., 2005;
Tashiro et al., 2009, 2010). We also succeeded in promoting
the differentiation of osteoblasts, adipocytes, or hepatoblasts
from ES and iPS cells by Ad vector-mediated transient transduc-
tion of Runx2, PPARγ, or Hex, respectively (Tashiro et al., 2009,
2008; Inamura et al., 2011).
Our data led us to examine whether HSPCs could also
be efficiently differentiated from ES and iPS cells by Ad
vector-mediated transduction of a HoxB4. In the present
study, we investigated whether or not differentiation of
HSPCs from mouse ES and iPS cells could be promoted bytransient HoxB4 expression. Our results showed that Ad
vector-mediated transient HoxB4 expression in mouse ES
and iPS cells are sufficient to augment the differentiation of
hematopoietic cells, including HSPCs, from mouse ES and iPS
cells. This result indicates that an Ad vector-mediated tran-
sient gene expression system would be a powerful and safe
tool to induce hematopoietic differentiation from mouse ES
and iPS cells.Results
Transduction with Ad vectors in ES-EBs or iPS-EBs
A previous study using a tetracycline-inducible HoxB4 ex-
pression system showed that hematopoietic stem/progeni-
tor cells (HSPCs) were generated by induction of HoxB4
expression in ES cell-derived embryoid bodies (ES-EBs) from
day 4 to day 6 of differentiation (Kyba et al., 2002), suggest-
ing that HoxB4 expression within this time range would be
effective for induction of hematopoietic cells. In addition,
CD41+c-kit+ cells in EBs are reported to be early hematopoi-
etic progenitor cells (Mitjavila-Garcia et al., 2002; Mikkola
et al., 2003). Thus, we planned to transduce HoxB4 in total
cells derived from ES- or iPS-EBs on day 5 of differentiation
or in CD41+c-kit+ cells derived from ES- or iPS-EBs on day
6. We initially investigated the expression of coxsackievirus
and adenovirus receptor (CAR) in ES-EB- or iPS-EB-derived
cells, because CAR was indispensable for transduction of an ex-
ogenous gene using Ad vector (Bergelson et al., 1997; Tomko et
al., 1997). Flow cytometric analysis showed the expression of
CAR in ES-EB- and iPS-EB-derived total cells and CD41+c-kit+
cells, although the expression levels of CAR in CD41+c-kit+
cells were decreased in comparison with that in total cells
(Figs. 1a and b). These results indicate that ES-EB- and iPS-
EB-derived total cells and CD41+c-kit+ cells could be trans-
duced with Ad vectors. We also observed the expression of
green fluorescent protein (GFP) in iPS-EB-derived total cells.
Because the mouse iPS cells used in this study express GFP
under the control of Nanog promoter (Okita et al., 2007), the
existence of GFP-positive cells showed that undifferentiated
iPS cells would still be present in iPS-EB-derived total cells.
We next examined the transduction efficiency in EB-derived
total cells or EB-derived CD41+c-kit+ cells using DsRed- or GFP-
expressing Ad vectors, respectively. After transduction with
Ad-DsRed or Ad-GFP at 3000 vector particles (VPs)/cell, the
cells were cultured with the hematopoietic cytokines for
2 days. The results showed that, at 3000 VPs/cell, approxi-
mately 60% or 40% of the EB-derived total cells or EB-derived
CD41+c-kit+ cells, respectively, expressed transgenes (Figs. 1c
and d). Although the number of transgene-expressing cells
was increased in the case of transduction with Ad vectors at
10,000 VPs/cell, the number of viable cells was markedly re-
duced (data not shown). Therefore, we decided to use Ad
vectors at 3000 VPs/cell for transducing human HoxB4
(hHoxB4) into ES-EBs and iPS-EBs. RT-PCR analysis on day 3
after transduction with Ad-hHoxB4 into EB-derived total
cells showed an elevation of hHoxB4 mRNA expression in
hHoxB4-transduced cells, while neither non-transduced
cells nor LacZ-transduced cells showed hHoxB4 expression
(Fig. 1e). Importantly, the expression level of hHoxB4 in
the cells was markedly decreased on day 6 after Ad
302 K. Tashiro et al.transduction. This result showed that the ES-EB- or iPS-EB-
derived cells could express transgenes by Ad vectors, and
that Ad vector mediated the transient transgene expression
in these cells.Transient HoxB4 expression augments the generation
of hematopoietic cells from mouse ES and iPS cellsTo induce and expand the hematopoietic cells from the iPS
cell line 38C2, EB-derived total cells were plated and cul-
tured on OP9 stromal cells with the hematopoietic cyto-
kines. On day 10 after plating on OP9 cells, the number of
38C2-derived hematopoietic cells in LacZ-transduced cells
was similar to that in non-transduced cells. On the other
hand, transient transduction of HoxB4 with Ad-hHoxB4
resulted in a significant increase in the number of hemato-
poietic cells compared with non-transduced cells or LacZ-
transduced cells (Fig. 2a, middle). Likewise, an increase in
the hematopoietic cell number by Ad vector-mediated
hHoxB4 transduction was also observed in ES cell derived-he-
matopoietic cells or the other iPS line 20D17-derived hema-
topoietic cells (Fig. 2a, left and right). Additionally, ES-EB-
or iPS-EB-derived CD41+c-kit+ cells, which were transiently
transduced with hHoxB4, could proliferate on OP9 stromal
cells for over 20 days (Fig. 2b). This result is mostly in agree-
ment with the previous report that ES cell-derived hemato-
poietic cells stably expressing HoxB4 had a growth
advantage in the presence of hematopoietic cytokines
(Pilat et al., 2005). Transient, but not stable, HoxB4 expres-
sion in ES-EB- or iPS-EB-derived cells would be sufficient to
augment the generation of hematopoietic cells from ES and
iPS cells.
We next investigated the surface antigen expression in non-
transduced cells, LacZ-transduced cells, or hHoxB4-trans-
duced cells after expansion on OP9 stromal cells. Flow cyto-
metric analysis revealed an increase of CD45 and CD41
expressions in HoxB4-transduced cells, compared with non-
transduced cells and LacZ-transduced cells (Figs. 3a and b).
CD45 is known as a marker of hematopoietic cells. In both in
vitro ES cell differentiation and a developing mouse embryo,
the expression of CD45 was developmentally controlled, and
CD45 expression was observed on hematopoietic cells after
expression of CD41 (Mitjavila-Garcia et al., 2002; Mikkola et
al., 2003). Thus, a higher percentage of CD45+ cells in
HoxB4-transduced cells would be due, at least in part, to an in-
crease of CD41 expression in HoxB4-transduced cells relative
to non-transduced cells and LacZ-transduced cells. We alsoFigure 1 Transduction with Ad vectors in ES-EB- or iPS-EB-derived
Ad, in ES-EB- or iPS-EB-derived total cells (a) or CD41+c-kit+ cells (b) w
cytometric analysis. As a negative control, the cells were incubated
tative experiment of three performed. (c, d) EB-derived total cells (c
were transduced with Ad-DsRed or Ad-GFP for 1.5 h, and transgene-
CD41+c-kit+ cells do not express GFP (Fig. 1b), Ad-GFP was used for t
in three independent experiments. (e) The expression level of human
on days 3 and 6 after transduction with Ad-hHoxB4 at 3000 VPs/cell
iPS, induced pluripotent stem; mCAR, mouse coxsackievirus and ad
trol.; VP, vector particle; RT, reverse transcription; GAPDH, glyceralfound a significant elevation of Sca-1 in hHoxB4-transduced
cells (Figs. 3a and b). Sca-1 is expressed in fetal and adult
HSPCs (Arai et al., 2004; McKinney-Freeman et al., 2009), al-
though Sca-1 expression was observed in other types of cells.
Therefore, our data suggest that immature hematopoietic
cells would be generated in hHoxB4-transduced cells more ef-
ficiently than in non-transduced cells or LacZ-transduced
cells.
In parallel with the flow cytometric analysis, we also ana-
lyzed the expression levels of hematopoietic marker genes in
iPS cell-derived hematopoietic cells by RT-PCR (Fig. 3c). The
expression levels of marker genes in LacZ-transduced cells
were mostly equal to those in non-transduced cells. In con-
trast, among the genes we assayed, the expression levels of
Gata-1, c-myb, and Cxcr4mRNA were slightly but significant-
ly up-regulated in hHoxB4-transduced cells. GATA-1 reflects
early hematopoietic development, whereas c-Myb is a mark-
er of definitive hematopoiesis (Godin and Cumano, 2002). In-
creased expression of these genes in HoxB4-transduced cells
suggests that transient hHoxB4 expression promotes the
production of both primitive and definitive hematopoiet-
ic progenitor cells from mouse ES and iPS cells. We could
not detect the hHoxB4 mRNA expression in Ad-hHoxB4-
transduced cells, confirming the transient hHoxB4 ex-
pression by Ad vectors (Fig. 3c).
HoxB4 expression enhances development of hemato-
poietic progenitor cells from mouse ES and iPS cells
To examine whether hematopoietic immature cells with he-
matopoietic colony-forming potential could be generated
from ES and iPS cells, ES cell-derived hematopoietic cells
and iPS cell-derived hematopoietic cells, both of which
were cultured on OP9 stromal cells for 10 days, were plated
and cultured in methylcellulose-containing media with he-
matopoietic cytokines. Without Ad transduction, the number
of total hematopoietic colonies in the iPS cell line 38C2 was
five times as high as that in ES cells, whereas another iPS cell
line, 20D17, had nearly the same hematopoietic differentia-
tion potential as ES cells (Fig. 4a). These results indicate
that there is a difference in hematopoietic differentiation
potential among iPS cell lines.
We next examined the hematopoietic colony potential in
LacZ-transduced cells or HoxB4-transduced cells. The colony
assay revealed a significant increase in the number of total
hematopoietic colonies in hHoxB4-transduced cells com-
pared with control cells, whereas there was no significant
difference in the number of hematopoietic colonies betweencells. (a, b) The expression levels of CAR, a primary receptor for
ere detected with anti-mouse CAR monoclonal antibody by flow
with an irrelevant antibody. Data shown are from one represen-
) or CD41+c-kit+ cells (d), purified by FACS (Supplemental Fig. 1),
expressing cells were then analyzed by flow cytometry. Because
ransduction into CD41+c-kit+ cells. Similar results were obtained
HoxB4 mRNA in the cells was examined by conventional RT-PCR
into EB-derived total cells. Abbreviations: ES, embryonic stem;
enovirus receptor; GFP, green fluorescent protein; Cont., con-
dehyde-3-phosphate dehydrogenase.Transduction with Ad vectors
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Note that the number of the most immature multipotent
progenitor cells, CFU-GEMM/CFU-Mix, in hHoxB4-transduced
cells was approximately seven times as great as that in non-
transduced cells or LacZ-transduced cells, and that large CFU-
Mix colonies were more frequently observed in hHoxB4-trans-duced cells than control cells (Fig. 4b and data not shown). A
colony assay after culturing on OP9 stromal cells for 20 days
also revealed that much number of myeloid (CFU-G, M, and
GM) colonies and CFU-Mix colonies were observed by transient
hHoxB4 transduction (Figs. 4c and d). Thus, our data clearly
showed that Ad vector-mediated transient hHoxB4 expression
Figure 2 The number of ES cell- or iPS cell-derived hematopoietic cells was significantly increased in Ad-hHoxB4-transduced cells. (a,
b) ES-EB- or iPS-EB-derived total cells (a) or CD41+c-kit+ cells (b) were transduced with Ad-LacZ or Ad-hHoxB4 at 3000 VPs/cell for 1.5 h,
and the cells were then plated on OP9 feeder cells. As a control, non-transduced cells were also plated on OP9 cells. After culturing on
OP9 feeders with the hematopoietic cytokines for 10 days (a) or 20 days (b), the number of hematopoietic cells per 2 wells of a 6-well
plate was counted. (a) Left, ES cells; middle, iPS cell line 38C2; right, iPS cell line 20D17. Results shown were the mean of four indepen-
dent experiments with indicated standard deviations. * pb0.05, ** pb0.01 as comparedwith non-transduced or Ad-LacZ-transduced cells.
304 K. Tashiro et al.enhances the differentiation of hematopoietic immature
cells, including HSPCs, from mouse ES and iPS cells.Discussion
Previous studies have shown that enforced expression of
HoxB4 is an effective strategy for hematopoietic differentia-
tion from both mouse and human ES cells (Kyba et al., 2002;
Bowles et al., 2006; Pilat et al., 2005; Schiedlmeier et al.,
2007). These studies usually used recombinant ES cells, such
as ES cells constitutively expressing HoxB4 (Pilat et al.,
2005) or ES cells containing a tetracycline (Tet)-inducible
HoxB4 expression system (Kyba et al., 2002), to induce hema-
topoietic cells. However, this expression system might raise
clinical concerns, including the risk of oncogenesis due to in-
tegration of transgenes into host genomes. In the present
study, we showed that Ad vector-mediated transient hHoxB4
expression in mouse ES-EB- or iPS-EB-derived cells could re-
sult in an efficient production of hematopoietic cells, includ-
ing HSPCs with a hematopoietic colony-forming ability, from
mouse ES and iPS cells (Figs. 2, 3, and 4). Our data obtained
in this report are largely consistent with previous reports
(Kyba et al., 2002) in which HSPCs were generated by using
ES cells containing the Tet-regulated HoxB4 expression cas-
sette. Therefore, a transient HoxB4 expression system using
an Ad vector, instead of a Tet-inducible HoxB4 expressionsystem, would contribute to safer clinical applications of ES
or iPS cell-derived hematopoietic cells.
Conventional Ad vector is known to infect the cells
through an entry receptor, CAR, on the cellular surface (Ber-
gelson et al., 1997; Tomko et al., 1997). Previously, we
showed that undifferentiated ES and iPS cells expressed
CAR, and conventional Ad vector could easily transduce a
foreign gene in more than 90% of the undifferentiated ES
and iPS cells at 3000 VPs/cell (Kawabata et al., 2005; Tashiro
et al., 2009). Like undifferentiated ES and iPS cells, we could
detect the CAR expression in more than 90% or 70% of EB-de-
rived total cells or EB-derived CD41+c-kit+ cells, respectively
(Figs. 1a and b). However, the transduction efficiency in EB-
derived total cells or CD41+c-kit+ cells was only 60% or 40%,
respectively, of the cells at most (Figs. 1c and d). Although
we are not certain why transgene expression was not ob-
served in all of CAR+ EB-derived cells, it is possible that the
promoter might not have worked in all of the cells because
the EB-derived total cells and CD41+c-kit+ cells were hetero-
geneous, unlike in the case of undifferentiated ES and iPS
cells. It is also possible that the Ad binding site of CAR
might be disrupted by trypsin treatment during the prepara-
tion of the EB-derived cells (Carson, 2000). Because the de-
velopment of efficient transduction methods in EB-derived
cells is considered to be a powerful tool to promote the he-
matopoietic differentiation from ES and iPS cells, further im-
provement of the transduction conditions will be needed.
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tion potential among mouse iPS cell lines (Fig. 4). Consistent
with our data, Kulkeaw et al. showed a difference in theFigure 3 Expression of surface antigen and hematopoietic marker g
cell line 38C2-derived cells were reacted with each antibody, and we
data from iPS cell line 38C2 are shown. (b) Percentage of each antige
cells (lower) is shown. The data expressed the mean of three indepe
** pb0.01 as compared with non-transduced or Ad-LacZ-transduced c
(Day 0), iPS-EB (Day 5), iPS cells-derived hematopoietic cells (day 15
(left) or quantitative real-time PCR (right) was then carried out as d
mean of three independent experiments with indicated standard dev
Ad-LacZ-transduced cells. Abbreviation: EBs, embryoid bodies; MEF, mhematopoietic differentiation capacity among six iPS cell
lines (Kulkeaw et al., 2010). In addition, recent studies
have reported that iPS cells leave an epigenetic memory ofenes in mouse ES cell- or iPS cell-derived cells. (a, b) ES cell- or iPS
re then subjected to flow cytometric analysis. (a) Representative
n positive cells in ES cell-derived cells (upper) or iPS cell-derived
ndent experiments with indicated standard deviations. * pb0.05,
ells. (c) Total RNA was extracted from undifferentiated iPS cells
), OP9 stromal cells, and MEF feeder, and semi-quantitative PCR
escribed in the Materials and methods. The data expressed the
iations. * pb0.05, ** pb0.01 as compared with non-transduced or
ouse embryonic fibroblast; GATA, GATA-binding protein.
Figure 3 (continued).
306 K. Tashiro et al.their cellular origin, and this memory influences their func-
tional properties, including in vitro differentiation (Kim et
al., 2010; Polo et al., 2010). Thus, these reports indicate
that, in order to obtain a large number of HSPCs from iPS
cells, it is necessary to choose an appropriate iPS cell
line, such as HSPC-derived iPS cells (Okabe et al., 2009).
Importantly, using mouse embryonic fibroblast-derived
iPS cells (38C2 and 20D17), we showed that the use of tran-
sient hHoxB4 transduction in iPS-EB-derived cells achieved
more effective differentiation into HSPCs than the use of
non-transduced cells (Fig. 4). Our method therefore should
be efficient for the production of HSPCs from any iPS cell
line.
An important but unsolved question in this study is
whether ES cell-derived hematopoietic cells and iPS
cell-derived hematopoietic cells transduced with Ad-
hHoxB4 have long-term hematopoietic reconstitution po-
tential in vivo. Recent studies have demonstrated that
some surface antigen expressions were different between
bone marrow-derived HSPCs and ES cell-derived HSPCs,
and that CD41+ cells had long-term repopulation ability
in ES cell-derived HSPCs (McKinney-Freeman et al.,
2009; Matsumoto et al., 2009). Our flow cytometric anal-
ysis revealed an increase of CD41+ cells in hHoxB4-trans-
duced cells compared with non-transduced cells and
LacZ-transduced cells (Fig. 3b). We also showed that
Ad-hHoxB4-transduced cells could proliferate on OP9
stromal cells more efficiently than control cells (Fig. 2).
Thus, these results suggest that immature hematopoietic
cells were generated by transient hHoxB4 transduction,
and that hHoxB4-transduced cells might have reconstitu-
tion potential in vivo. This in vivo transplantation analy-
sis is now on-going in our laboratory.In the present study, we succeeded in the promotion of
hematopoietic differentiation from mouse ES and iPS cells
by Ad vector-mediated hHoxB4 transduction. Ad vector
transduction can avoid the integration of transgene into
host genomes, and multiple genes can be transduced by Ad
vectors in an appropriate differentiation period. Thus, an
even more efficient protocol for hematopoietic differentia-
tion from ES and iPS cells could likely be established by co-
transduction of HoxB4 and other genes involved in the hema-
topoiesis, such as Cdx4 (Wang et al., 2005) and Scl/Tal1
(Kurita et al., 2006), using Ad vectors. Taken together, our
results show that Ad vector-mediated transient gene expres-
sion is valuable tool to induce hematopoietic cell from ES
and iPS cells, and this strategy would be applicable to safe
therapeutic applications, such as HSPC transplantation.Materials and methods
Antibodies
The following primary monoclonal antibodies (Abs), conjugat-
ed with fluorescein isothiocyanate (FITC), phycoerythrin (PE),
allophycocyanin (APC), or PE-Cy7, were used for flow cyto-
metric analysis: anti-CD45 (30-F11, eBioscience, San Diego,
CA), anti-CD11b (M1/70, eBioscience), anti-Sca-1 (D7,
eBioscience), anti-Ter-119 (Ter-119, eBioscience), anti-Gr-1
(RB6-8C5, eBioscience), anti-c-Kit (ACK2 or 2B8, eBioscience),
anti-CD41 (MWReg30, BD Bioscience San Jose, CA). Purified rat
anti-coxsackievirus and adenovirus receptor (CAR) was kindly
provided from Dr. T. Imai (KAN Research Institute, Hyogo,
Japan). For detection of CAR, the PE-conjugated donkey
anti-rat IgG (Jackson ImmunoResearch Laboratories, West
307Promotion of hematopoietic differentiation by transient HoxB4 transductionGrove, PA) or DyLight649-conjugated goat anti-rat IgG (BioLe-
gend, San Diego, CA) was used as secondary Abs.
Cell cultures
The mouse ES cell line E14 and two mouse iPS cell lines, 38C2
and 20D17, both of which were generated by Yamanaka and
his colleagues (Okita et al., 2007), were used in this study.
38C2was kindly provided by Dr. S. Yamanaka (Kyoto University,
Kyoto, Japan), and 20D17 was purchased from Riken Biore-
source Center (Tsukuba, Japan). In the present study, wemain-
ly used 38C2 iPS cells except where otherwise indicated. Mouse
ES and iPS cells were cultured in leukemia inhibitory factor-Figure 4 Significant increase of hematopoietic colony-forming cells
EB-derived cells were transduced with Ad-LacZ or Ad-hHoxB4, hemato
presence of hematopoietic cytokines for 10 days (a, b) or 20 days (c, d)
dium, and the number of hematopoietic colonies was then counted un
vided colonies by morphological subtype (BFU-E, CFU-G, CFU-M, CFU-
(38C2 and 20D17) was shown. Colony number was normalized to total
or four (a, b) independent experiments with indicated standard devi
Ad-LacZ-transduced cells. Abbreviation: BFU-E, burst-forming unit;
CFU-GM, CFU-granulocyte, monocyte; CFU-GEMM/CFU-Mix, CFU-granucontaining medium on a feeder layer of mitomycin C-
inactivated mouse embryonic fibroblasts (MEF) as described
previously (Tashiro et al., 2009). OP9 stromal cells were cul-
tured in α-minimum essential medium (αMEM: Sigma, St.
Louis, MO) supplemented with 20% fetal bovine serum (FBS),
2 mM L-glutamine (Invitrogen, Carlsbad, CA), and non-essential
amino acid (Invitrogen).Ad vectors
Ad vectors were constructed by an improved in vitro ligation
method (Mizuguchi and Kay, 1998, 1999). The shuttlein Ad-HoxB4-transduced hematopoietic cells. After ES-EB- or iPS-
poietic cells were generated by co-culturing with OP9 cells in the
. A colony-forming assay was performed usingmethylcellulose me-
der light microscopy. The number of total colonies (a, c) or subdi-
GM, and CFU-Mix) (b, d) generated from ES cells (E14) or iPS cells
number of the cells. Results shown were the mean of three (c, d)
ations. * pb0.05, ** pb0.01 as compared with non-transduced or
CFU-G, colony-forming unit-granulocyte; CFU-M, CFU-monocyte;
locyte, erythrocyte, monocyte, megakryocyte.
Figure 4 (continued).
308 K. Tashiro et al.plasmid pHMCA5, which contains the CMV enhancer/β-actin
promoter with β-actin intron (CA) promoter (a kind gift from
Dr. J. Miyazaki, Osaka University, Osaka, Japan) (Niwa et
al., 1991), was previously constructed (Kawabata et al.,
2005). The human HoxB4 (hHoxB4)-expressing plasmid,
pHMCA-hHoxB4, and DsRed-expressing plasmid, pHMCA-
DsRed, were generated by inserting a hHoxB4 cDNA (a kindly
gift from Dr. S. Karlsson, Lund University Hospital, Lund,
Sweden) and a DsRed cDNA (Clontech, Mountain View, CA),
respectively, into pHMCA5. pHMCA-hHoxB4 or pHMCA-
DsRed were digested with I-CeuI/PI-SceI and ligated into I-
CeuI/PI-SceI-digested pAdHM4 (Mizuguchi and Kay, 1998),
resulting in pAd-hHoxB4 or pAd-DsRed, respectively. Ad-
hHoxB4 and Ad-DsRed were generated and purified as de-
scribed previously (Tashiro et al., 2008). The CA promoter-
driven β-galactosidase (LacZ)-expressing Ad vector, Ad-
LacZ, and the CA promoter-driven GFP-expressing Ad vector,
Ad-CA-GFP, were generated previously (Tashiro et al.,
2008). The vector particle (VP) titer was determined by
using a spectrophotometrical method (Maizel et al., 1968).
In vitro differentiation
Prior to embryoid body (EB) formation, mouse ES or iPS
cells were suspended in differentiation medium (Dulbecco's
modified Eagle's medium (Wako, Osaka, Japan) containing
15% FBS, 0.1 mM 2-mercaptoethanol (Nacalai tesque, Kyoto,
Japan), 1×non-essential amino acid (Specialty Media, Inc.),
1×nucleosides (Specialty Media, Inc.), 2 mM L-glutamine (Invi-
trogen), and penicillin/streptomycin (Invitrogen)) and cul-
tured on a culture dish at 37 °C for 45 min to remove MEF
layers. Mouse ES cell- or iPS cell-derived EBs (ES-EBs or iPS-EBs, respectively) were generated by culturing ES or iPS cells
on a round-bottom low cell binding 96-well plate (Lipidure-
coat plate; Nunc) at 1×103 cells per well. ES-EBs or iPS-EBs
were collected on day 5, and a single cell suspension was pre-
pared by trypsin/EDTA treatment (Invitrogen) at 37 °C for
2 min. ES-EB- or iPS-EB-derived CD41+c-kit+ cells were sorted
by FACSAria (BD Bioscience). The purity of the CD41+c-kit+
cells was greater than 90% based on flow cytometric analysis
(Supplemental Fig. 1). Cells were then transduced with an
Ad vector at 3000 vector particles (VPs)/cell for 1.5 h in a
15 ml tube. After transduction, total cells (2×105) or
CD41+c-kit+ cells (1×104) were cultured on OP9 feeder cells
in a well of a 6-well plate in αMEM supplemented with 20%
FBS, 2 mM L-glutamine, non-essential amino acid, 0.05 mM 2-
mercaptoethanol, and hematopoietic cytokines (50 ng/ml
mouse stem cell factor (SCF), 50 ng/ml human Flt-3 ligand
(Flt-3L), 20 ng/ml thrombopoietin (TPO), 5 ng/ml mouse in-
terleukin (IL)-3, and 5 ng/ml human IL-6 (all from Peprotec,
Rocky Hill, NJ)). After culturing with OP9 stromal cells, both
non-adherent hematopoietic cells and adherent hematopoiet-
ic cells were collected as follows. The non-adherent hemato-
poietic cells were collected by pipetting and were
transferred to 15 ml tubes. The adherent hematopoietic cells
were harvested with the use of trypsin/EDTA, and then incu-
bated in a tissue culture dish for 30 min to eliminate the OP9
cells. Floating cells were collected as hematopoietic cells
and transferred to the same 15 ml tubes. These hematopoietic
cells were kept on ice for further analysis.
Flow cytometry
Cells (1×105 to 5×105) were incubated with monoclonal Abs
at 4 °C for 30 min and washed twice with staining buffer
Table 1 List of primers used for RT-PCR.
Gene name Species (5′) Sense primers (3′) (5′)Antisense primers (3′)
GAPDH Ms ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA
HoxB4 Hs AGAGGCGAGAGAGCAGCTT TTCCTTCTCCAGCTCCAAGA
Oct-3/4 Ms GTTTGCCAAGCTGCTGAAGC TCTAGCCCAAGCTGATTGGC
GFP – CACATGAAGCAGCACGACTT TGCTCAGGTAGTGGTTGTCG
Flk-1 Ms TCTGTGGTTCTGCGTGGAGA GTATCATTTCCAACCACCC
Gata1 Ms TTGTGAGGCCAGAGAGTGTG TTCCTCGTCTGGATTCCATC
Gata1 (real-time PCR) Ms GTCAGAACCGGCCTCTCATC GTGGTCGTTTGACAGTTAGTGCAT
Tel Ms CTGAAGCAGAGGAAATCTCGAATG GGCAGGCAGTGATTATTCTCGA
c-myb Ms CCTCACCTCCATCTCAGCTC GCTGGTGAGGCACTTTCTTC
β-H1 Ms AGTCCCCATGGAGTCAAAGA CTCAAGGAGACCTTTGCTCA
β-Major Ms CTGACAGATGCTCTCTTGGG CACAACCCCAGAAACAGACA
CXCR4 Ms GTCTATGTGGGCGTCTGGAT GGCAGAGCTTTTGAACTTGG
309Promotion of hematopoietic differentiation by transient HoxB4 transduction(PBS/2%FBS). Dead cells were excluded from the analysis by
7-amino actinomycin D (7-AAD, eBioscience). Analysis was
performed on an LSRFortessa flow cytometer by using FACS-
Diva software (BD Bioscience). For detection of transgene
expression by Ad vectors, EB-derived total cells or CD41+c-
kit+ cells were transduced with Ad-DsRed or Ad-CA-GFP, re-
spectively, for 1.5 h. At 48 h of incubation with the hemato-
poietic cytokines as described above, transgene expression
in the cells was analyzed by flow cytometry.Colony assay
A colony-forming assay was performed by plating ES cell-
derived hematopoietic cells or iPS cell-derived hemato-
poietic cells into methylcellulose medium M3434 (Stem
Cell Technologies, Vancouver, BC, Canada). After incuba-
tion at 37 °C and 5% CO2 for 10 to 14 days in a humidified
atmosphere, colony numbers were counted. The mor-
phology of colonies was observed using an inverted light
microscope.RT-PCR
Total RNA was isolated with the use of ISOGENE (Nippon
Gene, Tokyo, Japan). cDNA was synthesized by using Super-
Script II reverse transcriptase (Invitrogen) and the oligo(dT)
primer. Semi-quantitative PCR was performed with the use
of TaKaRa ExTaq HS DNA polymerase (Takara, Shiga,
Japan). The PCR conditions were 94 °C for 2 min, followed
by the appropriate number of cycles of 94 °C for 15 s,
55 °C for 30 s with 72 °C for 30 s and a final extension of
72 °C for 1 min, except for the addition of 5% dimethyl sulf-
oxide in the case of hHoxB4 cDNA amplification. The product
was assessed by 2% agarose gel electrophoresis followed by
ethidium bromide staining. Quantitative real-time PCR was
performed using StepOnePlus real-time PCR system with
FAST SYBR Green Master Mix (Applied Biosystems, Foster-
City, CA). The sequences of the primers used for in this
study are listed in Table 1.Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2011.09.001.Conflict of interest
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